Publications
12. Tkaczuk, KA, Van Echo, DA, Tait, N, Feldman, F, Lum, ZP, Lesko, S, Ts’o, POP;University of Maryland Greenebaum Cancer Center, Baltimore, MD/CCC Diagnostics, Baltimore, MD. Circulating Cancer Cells in Breast Cancer Patients. 2005 ASCO Meeting.
13. Ts’o, POP, Lesko, SA, Lum, ZP, Deamond, SF, Shan, E, Zhou, DB, Daniel JR. Personalized anticancer chemotherapy based on the measurement of drug response indicators (DRI) expressed by cancer cells. AACC 37th Oakridge Meeting, Abstract # 32, April 2005, Baltimore, MD.
14. Edelman, MJ, Bisaccia, S, Smith, R, Lesko, SA, Lum, ZP, Ts’o, POP; University of Maryland Greenebaum Cancer Center, Baltimore, MD/CCC Diagnostics LLC, Baltimore, MD. Circulating cancer cells (CCC) in non-small cell lung cancer (NSCLC): incidence and preliminary observations on prognostic significance and potential for individualized therapy. 2005 ASCO Meeting.
15. Ts’o, POP, Lesko, SA, Lum, ZP , Deamond, SF, Shan, E, Zhou, DB, Daniel, JR, CCC Diagnostics, LLC, Baltimore, MD. Drug Response Indicators in Cancer Cells Provide the Basis of Personalized Anticancer Chemotherapy. 7th Annual NIH SBIR/STTR Conference July 2005.
16. Ts’o, POP, Lesko, SA, Lum, ZP, Deamond, SF, Shan, E, Zhou, DB, Daniel, JR, Tkaczuk, KH, Tait, NS, Feldman, F, Van Echo DA, CCC Diagnostics, LLC, University of Maryland Greenebaum Cancer Center, HarborView Cancer Center, Baltimore, Maryland. Drug response indicators in cancer cells provide the bases of personalized anticancer chemotherapy (PAC) for breast cancer (BC). AACR Conference, September 2005, La Jolla, California.